ABOLOGIX
ABOLOGIX is developing best-in-class monoclonal antibodies by blocking the Junction Adhesion Molecule JAM-C and the extracellular matrix-related protein. The treatment is designed for patients that do not respond to traditional cancer therapies.
ABOLOGIX
Industry:
Biotechnology Medical Therapeutics
Founded:
2018-02-02
Address:
Plan-les-ouates, Geneve, Switzerland
Country:
Switzerland
Website Url:
http://www.abologix.com
Total Employee:
1+
Status:
Active
Contact:
+ 41 (022) 8801010
Email Addresses:
[email protected]
Total Funding:
160 K CHF
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Google GStatic Google Static Content Google Cloud Wix
Similar Organizations
Hookipa Pharma
Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Theolytics
Theolytics is a pre-clinical stage biotechnology company developing next-generation oncolytic viral therapies.
Current Employees Featured
Founder
Investors List
Venture Kick
Venture Kick investment in Debt Financing - Abologix
Venture Kick
Venture Kick investment in Grant - Abologix
Official Site Inspections
http://www.abologix.com
- Host name: 147.62.236.23.bc.googleusercontent.com
- IP address: 23.236.62.147
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Abologix"
Home | Abologix
Abologix obtains funding from the KICK FUND. Dec 23, 2024. Successful completion of the Innosuisse Innovation Project. Nov 23, 2023. Nomination of product H225 as the lead preclinical candidate. Dec 20, 2022. See more. Our …See details»
Abologix - Crunchbase Company Profile & Funding
Organization. Abologix . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... ABOLOGIX is developing best-in-class …See details»
Abologix Sàrl - Swiss Biotech
Abologix Sàrl . Swiss Biotech Association. Member. Claim / update listing; Profile ... Type of organization. Private company. Year of foundation. 2018. Number of employees in Switzerland. 1-9. Key business. R&D; Core competencies.See details»
ABOLOGIX Sàrl - S-GE
Switzerland Global Enterprise is the official Swiss organization for export and investment promotion. As a private consulting and platform organization commissioned by the …See details»
Abologix Sàrl - BioAlps
Avenue de Sécheron 15 1202 Geneva, Switzerland T +41 22 545 12 91. c/o BIOPÔLE SA Secteur Esplanade / Bâtiment Serine Route de la Corniche 8 1066 Epalinges, SwitzerlandSee details»
ABOLOGIX - Company Profile - Tracxn
Feb 24, 2025 ABOLOGIX - Developer of antibody therapeutics to treat non-Hodgkin´s lymphoma. Raised a total funding of $167K over 1 round from 4 investors. Founded by Beat …See details»
Abologix Sàrl - Drug pipelines, Patents, Clinical trials - Synapse
Explore Abologix Sàrl with its drug pipeline, therapeutic area, technology platform, , Technology Platform:Monoclonal antibody, Drug:SrpX2 mAB (Abologix). ... The statistics for drugs in the …See details»
ABOLOGIX - Products, Competitors, Financials, Employees, …
Abologix’s therapeutic option includes a monoclonal antibody, code-named H225, that blocks JAM-C. Learn more about Ignacio’s expectations for the Venture Leader Biotech experience …See details»
Abologix - Overview, News & Similar companies | ZoomInfo.com
Abologix contact info: Phone number: +41 228801010 Website: www.abologix.com What does Abologix do? ABOLOGIX is a biopharmaceutical company based in Geneva, Switzerland. It is …See details»
Abologix - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . May 26, 2021: Debt Financing …See details»
Abologix Sàrl - Venture Kick
May 27, 2021 Abologix Sàrl: ABOLOGIX develops novel therapeutics in oncology. The company´s lead program is a monoclonal antibody (code-named H-225) for the treatment of several sub-types of non-Hodgkin´s lymphoma …See details»
ABOLOGIX - VentureRadar
ABOLOGIX is developing best-in-class monoclonal antibodies by blocking the Junction Adhesion Molecule JAM-C and the extracellular matrix-related protein Olfactomedin-like protein 3 …See details»
Abologix Company Profile 2024: Valuation, Funding & Investors
Abologix General Information Description. Operator of a biopharmaceutical company intended to develop novel therapeutics designed for oncology treatment. The company offers a …See details»
Home | Abologix
Abologix has produced several recombinant anti-Olfml3 monoclonal antibodies. View more details. Founders. Ignacio Faus PhD. Ph.D. in Biochemistry from Indiana University MBA from …See details»
Abologix - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Abologix . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 3. About. Abologix has 3 …See details»
ABOLOGIX - Raised $167K Funding from 4 investors - Tracxn
Mar 10, 2025 ABOLOGIX has raised a total funding of $167K over 1 round from 4 investors. Investors include Venture Kick, Foundation Eclosion and 2 others. Their latest funding round …See details»
Scams Details - Better Business Bureau
Apr 23, 2024 Abologix. Date Reported. April 23, 2024. Scam ID. 835204. Similar to your experience? If you find a scam ID that matches your experience, tell us what happened and …See details»
Nextsource | Company Profile | Abologix
Find out if Abologix is undergoing leadership changes or executive team restructuring. Learn about mergers or acquisitions involving Abologix . Track key 'champions' at Abologix as they …See details»
ABOLOGIX Management Team - CB Insights
Explore {ABOLOGIX's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
Abologix wins CHF 150,000 to develop targeted antibodies for …
May 26, 2021 Abologix develops a new therapeutic option to treat lymphoma patients who have become resistant to conventional treatments. The Geneva-based biotech startup is a spin-out …See details»